Novel Test Identifies Lymphoma Patients Likely To Respond To New Therapy

... Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.The research was led by Dr. [click link for full article] ...